Title |
Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy
|
---|---|
Published in |
Clinical Ophthalmology, August 2014
|
DOI | 10.2147/opth.s35685 |
Pubmed ID | |
Authors |
Terry G Coursey, Cintia S de Paiva |
Abstract |
Dry eye from Sjögren's syndrome is a multifactorial disease that results in dysfunction of the lacrimal functional unit. Studies have shown changes in tear composition, including inflammatory cytokines, chemokines, and metalloproteinase. T-lymphocytes have been shown to increase in the conjunctiva and lacrimal glands in patient and animal models. This inflammation is in part responsible for the pathogenesis of the disease, which results in symptoms of eye irritation, ocular surface epithelial disease, and loss of corneal barrier function. There are a number of anti-inflammatory approaches for treating this disease. The current study reviews details of immune response and anti-inflammatory therapies used to control this disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 60% |
Bulgaria | 1 | 20% |
Canada | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Science communicators (journalists, bloggers, editors) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 1 | 1% |
Unknown | 88 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 15% |
Student > Master | 12 | 13% |
Student > Bachelor | 12 | 13% |
Student > Ph. D. Student | 11 | 12% |
Other | 7 | 8% |
Other | 17 | 19% |
Unknown | 17 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 43% |
Agricultural and Biological Sciences | 10 | 11% |
Nursing and Health Professions | 4 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Biochemistry, Genetics and Molecular Biology | 2 | 2% |
Other | 11 | 12% |
Unknown | 21 | 24% |